Covered recipient · General Payments record
BRIDGETTE A WOODALL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,566.46
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.73 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $56.84 | 3 |
| Astellas Pharma US Inc | $43.82 | 2 |
| Sumitomo Pharma America, Inc. | $37.84 | 2 |
| Amgen Inc. | $37.22 | 2 |
| Acerta Pharma LLC | $16.22 | 1 |
| Novo Nordisk AS | $15.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108435019 | CMS |
| ABBVIE INC. | $21.81 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108435021 | CMS |
| ABBVIE INC. | $20.04 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108435023 | CMS |
| Amgen Inc. | $16.94 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116213903 | CMS |
| Amgen Inc. | $20.28 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116213907 | CMS |
| Astellas Pharma US Inc | $20.71 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139468226 | CMS |
| Astellas Pharma US Inc | $23.11 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139509141 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.22 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105453713 | CMS |
| Novo Nordisk Inc | $15.79 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100321646 | CMS |
| Sumitomo Pharma America, Inc. | $21.12 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149005351 | CMS |
| Sumitomo Pharma America, Inc. | $16.72 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149005353 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.